⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Selective Androgen Receptor Modulators (SARMs)
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-10-03 — Myostatin inhibitors and the paradox of larger but weaker muscles: cross-connection with myostatin-inhibitors: Both intervention classes target lean mass preservation in sarcopenia/aging; the strength-decoupling observation is a shared evaluation criterion. (novelty: 3)
Open questions
Related
Contributing findings
Targeting skeletal muscle wasting: Emerging therapeutics and translational challenges.
10-sep-2026
novelty 2
per-area 2
strengthens